Tag: AFMD

Business

What Caused Affimed N.V (NASDAQ: AFMD) To Fall?

Affimed N.V (NASDAQ:AFMD) traded at $0.13 at close of the session on Tuesday, May 13 and made a downward move of -80.66% on its previous day’s price. Affimed N.V has a market cap of $2.04 million and is expected to release its quarterly earnings report

Market Summary

Affimed N.V. (AFMD): Are the Stars Lining Up for Investors?

Affimed NV (AFMD) unveiled how its immunological therapy has helped treat Hodgkin’s lymphoma. Even though the news only concerns four patients, it was well-received by investors. On April 13, AFMD shares were worth $ 9.89. The stock had gained more than 24% during the week.

Stocks Register
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.